AQUESTIVE THERAPEUTICS

Aquestive Therapeutics to Report Second Quarter 2021 Financial Results and Recent Business Highlights on August 3 and Host Conference Call on August 4 at 8:00 a.m. ET

21 7 2021 08:00:01 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film

19 7 2021 09:29:40 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film

24 6 2021 08:00:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer

21 6 2021 09:15:51 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences

09 6 2021 08:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics to Participate in 2021 RBC Capital Markets Global Healthcare Conference

11 5 2021 09:27:41 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

04 5 2021 19:53:36 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics to Report First Quarter 2021 Financial Results and Recent Business Highlights on May 4 and Host Conference Call on May 5 at 8:00 a.m. ET

21 4 2021 09:18:57 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Successfully Demonstrates Repeatable and Predictable Oral Sublingual Film Administration of Epinephrine

25 3 2021 08:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

09 3 2021 17:49:13 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ET

05 3 2021 07:00:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Reaffirms Near-Term NDA Resubmission for Libervant™ (diazepam) Buccal Film Following FDA Feedback

25 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET

17 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

09 2 2021 07:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy

28 1 2021 07:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics Provides Business Update

07 1 2021 07:30:00 提供 Nasdaq GlobeNewswire

Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

04 1 2021 07:30:00 提供 Nasdaq GlobeNewswire